Company page
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. is a public company traded under the ticker TRVI in the American market. The company has a market capitalization of approximately $2.53 billion. Trevi focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- TRVI:NASDAQ
- Asset type
- Stock
- Market cap
- $2.27B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD